United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp™ Featured in Dentistry Today


United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp™ Featured in Dentistry Today

COLTS NECK, N.J.--(BUSINESS WIRE)-- United Health Products, Inc. (OTCQB: UEEC.PK) and its wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp™, has been featured in the January 2013 edition of Dentistry Today. The article states that while there are other "hemostatic agents available to the dental practitioner, most of them are difficult to place, difficult to keep in position, and difficult to remove without disturbing the clotted surface, thereby reinitiating the bleeding. This specifically formulated gauze produces hemostasis almost instantly when positioned on a cut or wound. It contains no potentially harmful chemicals such as thrombin, collagen, or animal byproducts, is hypoallergenic, and works more quickly than other hemostatic agents. Once it has completed its task, it is readily dissolved by saline solution or water for easy removal that neither disturbs the clotted surface nor encourages re-bleeding." Dentistry Today is a top dental industry report offering comprehensive coverage of the latest news and developing technologies from within the dental industry through both print and online offerings.

Dr. Phillip Forman, CEO of United Health Products Inc., stated that "the coverage of our product by Dentistry Today continues to validate the HemoStyp™ gauze and our marketing efforts for its use within the dental industry." Dr. Forman went on to say that "In addition to Dentistry Today, our product was also highlighted several times in the last few months in the Clinicians Report® , another well known dental industry publication." In the December issue of the Clinicians Report®, HemoStyp™ was listed among the "Best Products Evaluated During 2012" with 83% of the evaluators stating that they would recommend the product. The company has received an initial order from one of the dental industry's largest dental products distributors. Dr. Forman further states that he hopes that the continued coverage and testimony by multiple industry publications generates the same kind of interest in the product. The January 2013 issue of Dentistry Today can be purchased or viewed at the following link for a nominal fee - http://www.dentistrytoday.com/articles/articles/185-table-of-contents/8497-january-2013

About United Health Products, Inc.

United Health Products, Inc. (UEEC) develops, manufactures and markets products and technologies in the healthcare sector. UEEC's operating subsidiary Epic Wound Care, Inc. produces hemostatic gauze, derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying emerging healthcare products and technologies for strategic partnership or acquisition.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

United Health Products, Inc.
Dr. Phillip Forman, 732-239-3444

KEYWORDS: United States North America New Jersey


The article United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp™ Featured in Dentistry Today originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Originally published